NES and breast carcinoma: Immunohistochemical analysis of FOXA1 and Nestin expression in breast cancer metastases revealed FOXA1-positivity and Nestin-positivity in 52 and 16% of the metastatic samples, respectively (Fig. 1, 2 and Table 1).